BackKiora Pharmaceuticals Overview

Kiora Pharmaceuticals Intangible Assets

Track Kiora Pharmaceuticals's intangible assets ($2.1M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Intangible Assets
$2.06M
69.15% YoYΔ $-4.62M vs prior year quarter

Peer trimmed avg / median

Loading

Kiora Pharmaceuticals Intangible Assets History

Loading

Kiora Pharmaceuticals vs. peers: Intangible Assets Comparison

Loading

Kiora Pharmaceuticals Intangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Kiora Pharmaceuticals (KPRX) FAQ

Kiora Pharmaceuticals (KPRX) currently reports a intangible assets of $2.1M as of June 2026. That compares with $6.7M in the prior-year period — down 69.1% year over year. Use the charts on this page to explore Kiora Pharmaceuticals's intangible assets history and peer comparisons.

Kiora Pharmaceuticals's intangible assets decreased from $6.7M to $2.1M — a 69.1% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Kiora Pharmaceuticals reported $2.1M in intangible assets as of June 2026. That compares with $6.7M in the prior-year period — down 69.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current intangible assets of $2.1M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Kiora Pharmaceuticals, and consider following KPRX for alerts when major investors trade the stock.

Kiora Pharmaceuticals is classified in the Healthcare sector. On intangible assets, it currently shows $2.1M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing KPRX with unrelated industries.